>
Switch to:

Akero Therapeutics EV-to-EBITDA

: -11.84 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Akero Therapeutics's enterprise value is $788.46 Mil. Akero Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was $-66.59 Mil. Therefore, Akero Therapeutics's EV-to-EBITDA for today is -11.84.

NAS:AKRO' s EV-to-EBITDA Range Over the Past 10 Years
Min: -79.64   Med: 0   Max: 0
Current: -11.84

-79.64
0
NAS:AKRO's EV-to-EBITDA is ranked lower than
99.99% of the 272 Companies
in the Biotechnology industry.

( Industry Median: 32.84 vs. NAS:AKRO: -11.84 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2021-01-24), Akero Therapeutics's stock price is $31.060000. Akero Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was $-2.17. Therefore, Akero Therapeutics's PE Ratio for today is .

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Akero Therapeutics EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Akero Therapeutics Annual Data
Dec17 Dec18 Dec19
EV-to-EBITDA 0.00 0.00 -10.90

Akero Therapeutics Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.49 -10.90 -9.12 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Akero Therapeutics EV-to-EBITDA Distribution

* The bar in red indicates where Akero Therapeutics's EV-to-EBITDA falls into.



Akero Therapeutics EV-to-EBITDA Calculation

Akero Therapeutics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=788.458/-66.592
=-11.84

Akero Therapeutics's current Enterprise Value is $788.46 Mil.
Akero Therapeutics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was -16.221 (Dec. 2019 ) + -12.379 (Mar. 2020 ) + -16.454 (Jun. 2020 ) + -21.538 (Sep. 2020 ) = $-66.59 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Akero Therapeutics  (NAS:AKRO) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Akero Therapeutics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=31.060000/-2.17
=

Akero Therapeutics's share price for today is $31.060000.
Akero Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was -0.55 (Dec. 2019 ) + -0.42 (Mar. 2020 ) + -0.57 (Jun. 2020 ) + -0.63 (Sep. 2020 ) = $-2.17.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Akero Therapeutics EV-to-EBITDA Related Terms


Akero Therapeutics EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)